Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07469163

Phase I Split-Belt Treadmill Dosing for Subacute Stroke

NeuroRecoVR: Phase I Split-Belt Treadmill Dosing for Subacute Stroke

Status
Recruiting
Phase
Phase 1
Study type
Interventional
Enrollment
72 (estimated)
Sponsor
University of Calgary · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

After experiencing a stroke, many individuals encounter difficulties with walking and balance, which can significantly impact their independence. Recent studies have indicated that split-belt treadmill (SBT) training is effective for improving gait metrics, including walking speed and step length asymmetry. The SBT allows each leg to move at different speeds, which has been shown to help chronic stroke survivors learn to walk more symmetrically. However, there is limited knowledge about the dose participants should receive and the safety of SBT training in the early stages of recovery, which is a crucial period for rehabilitation. To address this gap, we are evaluating an innovative SBT with virtual reality (VR) features at the Foothills Medical Center. Our objective is to conduct a study to determine the amount of SBT training patients can tolerate in a day. In this study, stroke survivors will engage in a series of walking exercises on the SBT. We will escalate the duration of SBT walking until participants reach a point where they can no longer continue due to dose-limiting criteria such as fatigue or discomfort. The findings from this initial phase will guide future larger trials to explore the effectiveness of this training method. Ultimately, we aspire to improve rehabilitation strategies for stroke survivors, assisting them in regaining mobility and enhancing their quality of life more effectively.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSplit-Belt TreadmillParticipants undertake 5 days of treadmill walking. Each day is broken into 3 episodes: A) two-minutes tied-belt walking, B) n minutes split-belt walking (dose escalating component), C) 10-minutes tied-belt walking. Split-belt walking will start at a dose of 8-minutes and escalate by 3 minute increments, up to a maximum dose of 30 minutes.

Timeline

Start date
2026-03-01
Primary completion
2026-08-31
Completion
2026-08-31
First posted
2026-03-13
Last updated
2026-03-13

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT07469163. Inclusion in this directory is not an endorsement.